Leadership Succession Ensures Continuing Efforts to Improve Global Health
Prior to joining WHO in 1995, Dr. Quick had worked for over 20 years on issues of international health in more than 25 countries in Africa, Asia, and Latin America, including almost 10 years with MSH. During his time at MSH, Dr. Quick started MSH's Drug Management Program (now the Center for Pharmaceuticals Management) and later served as a resident advisor in Pakistan and then Kenya. He has written numerous books and articles on global health and served as Senior Editor for MSH's Managing Drug Supply, a standard reference recognized around the world.
MSH was founded more than 30 years ago and works collaboratively with health care policymakers, managers, providers, and consumers to help close the gap between what is known about important public health problems and what is done to solve them. Dr. Quick's appointment as President and CEO ensures continued leadership in this area according to Dr. O'Connor, who said, "…as in any human endeavor, in the final analysis what matters most is what we do, not just what we say. We at MSH share a mission and common values that help us stay focused on the most important issues in world health. I am confident that Jono Quick will be a great leader for that effort."
In the meeting at which the announcement of Dr. Quick's appointment was made, Dr. William F. Pounds, Dean and Professor Emeritus at MIT's Sloan School of Management and Chair of MSH's Board of Directors, reflected on both Dr. O'Connor's work and the opportunity ahead. "Ron O'Connor conceived MSH. Thanks to his vision, MSH has been a great success. Ron and the Board faced a very high standard in planning this transition. We are proud of what MSH has accomplished, but we are also confident that Dr. Jonathan Quick will lead MSH to make even greater contributions in the years ahead. The need continues to grow."
Upon accepting the position, Dr. Quick stated that: "MSH has a long history of helping countries make practical improvements in their health systems—thereby reducing needless suffering and saving countless lives. I hope to help MSH build on this success to have an even greater impact in the future." Dr. Quick assumes leadership over an MSH organization that employs over 1000 people and is currently working in more than 50 countries worldwide. MSH's annual budget is more than 75 million dollars.